UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN, E9
Enters Into Contingent Value Rights Agreement
Shareholder votes
Other Events
CYPRESS Study 0197 Update
Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Agrees to be Acquired
Dr. Áine Miller to Depart as SVP of Development on November 15, 2026
2026 Annual Meeting Results - Directors Elected for Theravance Biopharma
Q2
Q1
FY 2025
Q3
FY 2024
Notice of Suspension of Duty to File Reports
SC TO-I
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Merger Proxy Statement
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
S-8 POS